Dublin, Nov. 10, 2026 (GLOBE NEWSWIRE) -- "Genotyping - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering.
The global genotyping market was valued at US$22.8 billion in 2025 and is projected to reach US$65 billion by 2032, expanding at a compound annual growth rate (CAGR) of 16.1% over the forecast period. Market growth is being supported by rising demand for personalized medicine, continued advances in next-generation sequencing (NGS), expanding genomic research programs, and broader adoption across healthcare, agricultural biotechnology and pharmaceutical development.
Genotyping has become integral to clinical diagnostics, pharmacogenomics, oncology research, crop improvement and animal genetics. In healthcare, genetic analysis supports the identification of disease-associated variants, patient stratification and treatment selection. Its growing role in precision oncology is particularly significant, as the detection of mutations involving genes such as BRCA1, BRCA2 and EGFR can inform targeted treatment strategies and improve clinical decision-making.
Pharmacogenomics is also strengthening demand for genotyping products and services. Genetic variants affecting drug metabolism can influence treatment efficacy, dosage requirements and the risk of adverse reactions. Incorporating genomic information into prescribing decisions can help healthcare providers optimize therapies and reduce reliance on trial-and-error treatment approaches.
Technology Advances Improve Genotyping Speed, Scale and Accuracy
NGS, high-density microarrays, polymerase chain reaction technologies, capillary electrophoresis and mass spectrometry are advancing the scale and precision of genotyping workflows. NGS platforms enable high-throughput analysis across large numbers of samples and genetic markers, supporting population studies, clinical trials, genome-wide association studies and translational research.
Single nucleotide polymorphism arrays remain important for analyzing variants associated with diseases, inherited traits and population ancestry. Their affordability and capacity for large-scale processing have supported adoption in research institutions, clinical laboratories and direct-to-consumer genetic testing services.
Bioinformatics, artificial intelligence and machine learning are further improving the interpretation of genomic data. These technologies help researchers identify relevant variants, connect genotypes with phenotypes and evaluate potential associations with disease risk or treatment outcomes. As genomic datasets increase in size and complexity, advanced analytical software and services are expected to represent an increasingly important part of the genotyping market.
Precision Agriculture Creates Additional Growth Opportunities
Agricultural biotechnology is another major application area. Genotyping enables researchers and breeders to select crops and livestock with commercially valuable characteristics, including higher yields, improved nutritional profiles, disease resistance and tolerance to drought or extreme temperatures.
Marker-assisted breeding can accelerate the development of resilient crop varieties while reducing dependence on pesticides and other chemical inputs. In livestock production, genotyping supports productivity improvements, genetic diversity management and the identification of inherited disorders. These capabilities are becoming more important as population growth, climate volatility and food security concerns increase pressure on global agricultural systems.
Key Genotyping Market Growth Drivers
- Increasing adoption of personalized and precision medicine across oncology, cardiology and pharmacogenomics.
- Falling sequencing costs and greater availability of scalable genetic testing platforms.
- Government and private-sector investment in national genomics programs and population-based research.
- Growing use of genomic biomarkers in pharmaceutical research, clinical trials and companion diagnostics.
- Expansion of agricultural genotyping for crop optimization, livestock health and sustainable food production.
- Continued consumer demand for ancestry, health-risk and inherited-trait testing services.
Large genomic initiatives, including the UK's 100,000 Genomes Project and the U.S. Precision Medicine Initiative, have also contributed to market development by supporting extensive data generation, infrastructure investment and clinical integration. These programs create opportunities for instrument manufacturers, reagent suppliers, software developers, testing laboratories and genomic service providers.
Market Segment and Regional Outlook
The report analyzes the global genotyping market by component, technology, application, end use and geography. Component categories include instruments, reagents and kits, and software and services. Technologies covered include PCR, capillary electrophoresis, microarrays, sequencing, mass spectrometry and other platforms.
Application analysis encompasses pharmacogenomics, diagnostics and personalized medicine, agricultural biotechnology, animal genetics and other uses. End-user coverage includes pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutions and additional organizations.
The instruments segment is forecast to reach US$35.3 billion by 2032, advancing at a CAGR of 18.4%. The reagents and kits segment is projected to grow at a CAGR of 12.7% during the analysis period.
Geographically, the U.S. genotyping market was valued at US$6.7 billion in 2025. China is forecast to expand at a CAGR of 15.3% and reach US$11.1 billion by 2032. The report also evaluates market trends and competitive conditions across Canada, Japan, Germany, France, Italy, the United Kingdom, the rest of Europe, Asia-Pacific and the rest of the world.
Competitive Landscape
The genotyping market includes global life sciences companies, diagnostic technology providers, laboratory service organizations and specialized genetics businesses. Companies featured in the report include:
- Agilent Technologies, Inc.
- Beckman Coulter, Inc.
- Benchmark Genetics AS
- F. Hoffmann-La Roche AG
- GE Healthcare
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Qiagen NV
- Standard BioTools Inc.
- Thermo Fisher Scientific, Inc.
Report Scope and Strategic Value
The global genotyping market report provides annual market estimates and forecasts from 2025 through 2032, presented in US$ million. It examines competitive positioning, regional development, technology adoption, segment performance and emerging commercial opportunities. Company profiles provide additional insight into organizations participating in and influencing the competitive environment.
The analysis is designed to help executives, investors, product developers, research institutions and strategic planners assess market direction, identify growth opportunities and evaluate the factors influencing demand. It addresses how the genotyping market is expected to evolve through 2032, which segments are positioned for the strongest growth, how regional market shares may change and which companies are shaping the industry.
Purchasers also receive complimentary report updates for one year, providing access to relevant market developments following publication.
Domain Expert Insights
The report incorporates perspectives from domain experts across industry, enterprise and academia, adding strategic context beyond conventional secondary research. The report tracks early market signals emerging from expert discussions, corporate activity, conference sessions, keynote presentations, panel discussions, company disclosures, annual reports, institutional publications and other validated sources.
These inputs are synthesized to assess where the market is moving, what is driving that direction and which developments are most relevant to business strategy. The analysis extends beyond market-level forecasts to examine participating companies and the forces shaping competition.
Market share is evaluated where it provides meaningful strategic value. Because competitive structures can vary significantly by geography, the report applies region-specific analysis when appropriate rather than relying solely on a single global market share figure. This approach provides a more precise view of the global genotyping market and its evolving commercial landscape.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 215 |
| Forecast Period | 2025-2032 |
| Estimated Market Value (USD) in 2025 | $22.8 Billion |
| Forecasted Market Value (USD) by 2032 | $65 Billion |
| Compound Annual Growth Rate | 16.1% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/n8m528
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
